CALCUTIONS AREA
CLICK ON CALCULATOR
Infant Data
Results
MEDICAL INFORMATIONS
INDICATIONS
- Refractory hyperinsulinemic hypoglycemia.
- Congenital and postoperative chylothorax, Adjunct.
ADVERSE EFFECTS
- Vomiting, diarrhea, abdominal distention and steatorrhea may occur.
- Pulmonary hypertension has been reported in treated former premature infants with chronic lung disease.
- Necrotizing enterocolitis has been reported in term neonates receiving octreotide for the treatment of hyperinsulinemic hypoglycemia (6 cases) and chylothorax (2 cases).
- Hyperglycemia may occur in patients being treated for chylothorax.
ADMINISTRATION
- Subcutaneous: To minimize pain, use smallest volume to deliver dose. Rotate sites.
- Intravenous:
- May give IV push over 3 minutes (or rapid IV bolus in emergency situations) or by intermittent IV infusion over 15 to 30 minutes in compatible solution at a concentration of 10 to 25 mcg/mL.
- May also give by continuous IV infusion. Dilutions as low as 1 mcg/mL can be used.
MONITORING
- Monitor blood glucose closely.
- Monitor for signs and symptoms of necrotizing enterocolitis.